ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,983.99
      -0.29%
      US Tech 100
      20,480.38
      -0.36%
      Dow Jones
      43,910.98
      -0.86%
      Brent Oil
      71.995
      0.52%
      Bitcoin
      87,290.74
      -0.72%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Organon and Co (OGN)

      7. Organon and Co (OGN) Financials

      Organon and Co

      Organon and Co (OGN)

      Origin Enterprises Plc
      Orogen Royalties Inc
      15.58
      -0.51
      (-3.17%)
      Closed November 13 4:00PM
      Delayed by 15 minutes
      15.61
      0.025
      (0.16%)
      After Hours: 7:06PM
      Delayed by 15 minutes

      Organon and Co Financial Summary

      The current OGN market cap is 4.02B. The company's latest EPS is USD 3.9722 and P/E is 3.92.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.52B1.6B1.62B1.61B1.58B
      Operating Income 232M254M376M371M339M
      Net Income 58M546M201M195M359M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 9.53B8.1B6.3B6.17B6.26B
      Operating Income 3.55B2.71B1.81B1.57B1.26B
      Net Income 3.22B2.16B1.35B917M1.02B

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 11.01B12.06B11.89B12.15B12.75B
      Total Liabilities 11.6B12.13B11.84B12.01B12.26B
      Total Equity -589M-70M48M144M493M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 10.55B9.92B10.68B10.96B12.06B
      Total Liabilities 3.51B4.43B12.19B11.85B12.13B
      Total Equity 7.04B5.49B-1.51B-892M-70M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 402M799M76M408M549M
      Investing -179M-260M-96M-142M-217M
      Financing -492M-569M-74M-208M-286M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 2.77B2.19B2.46B858M799M
      Investing -102M-258M-481M-420M-260M
      Financing -2.62B-2.18B-1.33B-433M-569M

      Stats and Ratios

      Market Cap 4.02B
      Price to Earnings Ratio 3.92
      Price to Sales Ratio 0.64
      Price to Cash Ratio 5.79
      Price to Book Ratio -57.32
      Dividend Yield 7.17%

      Share Statistics

      Shares Outstanding 257.54M
      Average Volume (1 week) 4.34M
      Average Volume (1 Month) 2.87M
      52 Week Change 41.78%
      52 Week High 23.10
      52 Week Low 10.835
      Spread (Intraday) 0.07 (0.45%)

      Company Info

      Company Name Organon and Co
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.organon.com
      Industry pharmaceutical preparations (2834)